文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌根治性放疗后局部失败的挽救性再程放疗:直肠毒性与剂量分布及正常组织并发症概率模型的关联

Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models.
PubMed 文献 · Adv Radiat Oncol · 2018-06-15

本研究评估了前列腺癌根治性外照射放疗(EBRT)后局部失败患者接受挽救性EBRT(联合或不联合近距离放疗)时,直肠剂量对直肠毒性的影响。14例患者在初治EBRT后中位6.1年接受再程放疗,中位NTD2Gy初治为74 Gy、再程为85.1 Gy。初治时直肠V70Gy和D1ccrect可预测≥3级胃肠道毒性,初治NTCP>10%与再程放疗后高胃肠道毒性相关,D1ccrect阈值可能为130 Gy。

要点

  • 初治EBRT时直肠V70Gy(9% vs 0%;P=.04)和D1ccrect(72.2 Gy vs 66.8 Gy;P<.01)均可预测再程放疗后≥3级胃肠道毒性。
  • 初治联合再程放疗计划时,高胃肠道毒性组中位D1ccrect为139.8 Gy,低胃肠道毒性组为126.7 Gy(P<.01)。
  • 初治时NTCP>10%可预测再程放疗后高胃肠道毒性(P<.05),D1ccrect阈值可能为130 Gy。

核心结论

  • 即使初治放疗后无残留毒性,初治时直肠剂量>70 Gy和NTCP>10%可能与再程放疗后发生高胃肠道毒性的风险较高相关,D1ccrect阈值可能为130 Gy。

研究设计与样本

  • 本研究纳入14例前列腺癌初治EBRT(联合或不联合近距离放疗)后无严重残留晚期毒性、出现单纯局部失败的患者,在中位时间间隔6.1年后接受再程放疗。
  • 初治EBRT中位NTD2Gy(α/β=1.5 Gy)为74 Gy,再程放疗中位NTD2Gy为85.1 Gy。
  • 评估直肠剂量体积直方图(转换为NTD2Gy_α/β=3 Gy)及胃肠道毒性对应的NTCP值,分为高胃肠道毒性组(≥3级)和低胃肠道毒性组(≤2级)两组。

主要发现

  • 5年≥3级胃肠道毒性无事件生存率为57.1%。
  • 初治EBRT时中位直肠V70Gy在高胃肠道毒性组为9%、低胃肠道毒性组为0%(P=.04),中位D1ccrect分别为72.2 Gy和66.8 Gy(P<.01)。
  • 初治联合再程放疗计划时,高胃肠道毒性组中位D1ccrect为139.8 Gy,低胃肠道毒性组为126.7 Gy(P<.01)。
  • 初治时NTCP>10%可预测再程放疗后高胃肠道毒性(P<.05)。

关键数值与推荐

  • 初治EBRT时直肠V70Gy:高胃肠道毒性组9% vs 低胃肠道毒性组0%(P=.04)。
  • 初治EBRT时D1ccrect:高胃肠道毒性组72.2 Gy vs 低胃肠道毒性组66.8 Gy(P<.01)。
  • 初治联合再程放疗计划时D1ccrect:高胃肠道毒性组139.8 Gy vs 低胃肠道毒性组126.7 Gy(P<.01)。
  • 初治时NTCP>10%预测再程放疗后高胃肠道毒性(P<.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to assess the impact of radiation dose on rectal toxicity after salvage external beam radiation therapy (EBRT) with or without a brachytherapy boost for exclusive local failures after the primary EBRT for prostate cancer. METHODS AND MATERIALS: Fourteen patients with no severe residual late toxicity after primary EBRT ± brachytherapy were reirradiated after a median time interval of 6.1 years. The median normalized total dose in 2 Gy fractions (NTD2Gy, α/β ratio = 1.5 Gy for prostate cancer cells) was 74 Gy at primary EBRT and 85.1 Gy at reirradiation. Rectal dose-volume histograms (converted to NTD2Gy_alpha/beta = 3 Gy) and the corresponding normal-tissue complication probability (NTCP) values for gastrointestinal (GI) toxicity were evaluated for 2 groups: High GI toxicity (grade ≥3) and low GI toxicity (grade ≤2). RESULTS: The 5-year grade ≥3 GI toxicity-free survival rate was 57.1%. The median rectal V70Gy and maximum dose to 1 cm3 (D1ccrect) at primary EBRT were both predictive for grade ≥3 GI toxicity (9% vs 0%; P = .04 and 72.2 Gy vs 66.8 Gy; P < .01, respectively). When adding primary radiation therapy (RT) and reirradiation plans, the median D1ccrect was 139.8 Gy versus 126.7 Gy (P < .01) for high and low GI toxicity groups. NTCP >10% at primary RT was predictive for high GI toxicity at reirradiation (P < .05). CONCLUSIONS: Even in the absence of residual toxicity after primary RT, rectal doses >70 Gy and NTCP >10% calculated for a first irradiation may be associated with a higher risk of developing high GI toxicity at reirradiation with a possible D1ccrect threshold of 130 Gy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Dipasquale G, Zilli T, Fiorino C, et al. Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models. Adv Radiat Oncol. 2018. PMID: 30370369. doi:10.1016/j.adro.2018.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。